Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.

Piotr DomańskiJadwiga JarosińskaBarbara KruczykMateusz PiętakAnna MydlakTomasz DemkowŁukasz KuncmanMarta DarewiczBożena Sikora-KupisPaulina DumnickaJakub Kucharz

Published in: Contemporary oncology (Poznan, Poland) (2023)

Cabozantinib has antitumor effects in the second and further lines of treatment. In this study we observed high efficiency of cabozantinib in further lines of treatment.

Keyphrases

high efficiency
squamous cell carcinoma
small cell lung cancer
metastatic renal cell carcinoma
replacement therapy